{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:17:55Z","timestamp":1791033475595,"version":"4.1.0"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We describe the molecular characterization of a multiresistant<jats:italic>Pseudomonas aeruginosa<\/jats:italic>clone causing an outbreak in the intensive care unit (ICU) of a tertiary-care university hospital. Analysis included antimicrobial susceptibility profile, O-serotyping, pulsed-field gel electrophoresis, and amplified fragment length polymorphism. Resistance mechanisms were characterized, including production of naturally occurring and acquired \u03b2-lactamases, porin expression, and efflux pump systems. Eighteen patients were colonized or infected with multiresistant<jats:italic>P. aeruginosa<\/jats:italic>. Multiresistant<jats:italic>P. aeruginosa<\/jats:italic>was panresistant to penicillins, cephalosporins, carbapenems, aminoglycosides, and fluoroquinolones and remained susceptible only to colistin. Sixteen isolates (89%) belonged to serotype O:11, pulsed-field gel electrophoresis type A1, and amplified fragment length polymorphism type A. Resistance characterization of this epidemic clone showed an overexpression of the chromosomal cephalosporinase AmpC combined with decreased expression of porin OprD and the absence of metallo-\u03b2-lactamase or extended-spectrum beta-lactamase. An upregulation of the MexXY efflux system due to an<jats:italic>agrZ<\/jats:italic>mutation in the<jats:italic>mexZ<\/jats:italic>repressor was detected. This epidemic clone was restricted to the ICU and was not found elsewhere in hospital. Contamination of the ICU environment and the hands of an ICU nurse with this clone suggests possible hand-borne transmission. Implementation of contact precautions effectively controlled transmission of the epidemic clone. This study illustrates the ability of multiresistant<jats:italic>P. aeruginosa<\/jats:italic>to cause an outbreak with significant morbidity and mortality and underscores the need to identify clonal outbreaks, which require targeted infection control measures.<\/jats:p>","DOI":"10.1128\/jcm.43.3.1198-1204.2005","type":"journal-article","created":{"date-parts":[[2005,3,4]],"date-time":"2005-03-04T23:47:54Z","timestamp":1109980074000},"page":"1198-1204","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":116,"title":["Molecular Characterization of an Epidemic Clone of Panantibiotic-Resistant<i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1128","volume":"43","author":[{"given":"A.","family":"Deplano","sequence":"first","affiliation":[{"name":"Department of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Denis","sequence":"additional","affiliation":[{"name":"Department of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Poirel","sequence":"additional","affiliation":[{"name":"Service de Bacte\u0301riologie-Virologie, Ho\u0302pital de Bice\u0302tre, Faculte\u0301 de Me\u0301decine, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hocquet","sequence":"additional","affiliation":[{"name":"Laboratoire de Bacte\u0301riologie, Ho\u0302pital Jean Minjoz, Besanc\u0327on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nonhoff","sequence":"additional","affiliation":[{"name":"Department of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Byl","sequence":"additional","affiliation":[{"name":"Infection Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nordmann","sequence":"additional","affiliation":[{"name":"Service de Bacte\u0301riologie-Virologie, Ho\u0302pital de Bice\u0302tre, Faculte\u0301 de Me\u0301decine, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Vincent","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Erasme Hospital, Universite\u0301 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Struelens","sequence":"additional","affiliation":[{"name":"Department of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/502082"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0195941700072726"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-5-394"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009073431004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.1.175-182.2001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2001.044"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.4.943"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1887-1894.2003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1003.020799"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1797-1802.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.6.1041"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/321890"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/501739"},{"key":"e_1_3_2_15_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3201\/eid0601.000117","volume":"6","year":"2000","unstructured":"Poirel, L., L. Collet, and P. Nordmann. 2000. Carbapenem-hydrolyzing metallo-beta-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France. Emerg. Infect. Dis.6:84-85.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3542-3547.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.891-897.2000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2598-2603.2001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00763.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45620-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.11.3654-3661.1999"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90331-I"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(96)90055-9"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.4.897-901.1998"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/501828"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00642.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050002"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530080055041"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1676-1680.2004"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.8.2755-2759.2002"},{"key":"e_1_3_2_32_2","first-page":"33","volume":"6","year":"1994","unstructured":"Wenzel, R. P. 1994. Healthcare workers and the incidence of nosocomial infection: can treatment of one influence the other? a brief review. J. Chemother.6(Suppl. 4):33-37.","journal-title":"J. Chemother."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.3.372"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.3.1198-1204.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.3.1198-1204.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T21:45:12Z","timestamp":1735163112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.3.1198-1204.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1128\/JCM.43.3.1198-1204.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.3.1198-1204.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2004-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}